Wegovy is now available in pill form. The FDA approved oral Wegovy tablets, making semaglutide the first GLP-1 weight loss medication available as both an injection and a daily pill. The tablet version is taken once a day at a maintenance dose of 25 mg, compared to the once-weekly 2.4 mg injection most people associate with Wegovy.
How the Pill Version Works
Semaglutide is a protein-based molecule, which means stomach acid would normally destroy it before it could reach your bloodstream. The pill gets around this by pairing semaglutide with an absorption enhancer called SNAC, a small fatty acid compound that does two things at once: it neutralizes stomach acid in the immediate area around the tablet, protecting the drug from being broken down, and it temporarily increases the permeability of the stomach lining so semaglutide can pass through into the bloodstream.
This absorption process is fragile, which is why the pill comes with strict dosing rules. You need to take it first thing in the morning on an empty stomach, with no more than about 4 ounces of plain water (roughly half a glass). Then you wait at least 30 minutes before eating, drinking anything else, or taking other medications. Food, beverages (even mineral water), and other pills in your stomach will reduce how much semaglutide your body actually absorbs. Fasting longer than 30 minutes after taking the pill can actually increase absorption.
Dosing Differences: Daily Pill vs. Weekly Shot
The oral version requires a much higher milligram dose than the injection because only a small fraction of the drug survives the trip through your stomach. The pill’s maintenance dose is 25 mg taken every day, while the injectable version delivers 2.4 mg once a week. Your prescriber will start you at 1.5 mg daily and increase the dose every 30 days until you reach the full 25 mg, a gradual ramp-up designed to reduce side effects.
Despite the different dosing numbers, both forms deliver semaglutide into your bloodstream to do the same job: mimicking a gut hormone called GLP-1 that reduces appetite and slows digestion.
Weight Loss Results With the Pill
Clinical trials have shown the oral version produces weight loss comparable to what people expect from the injection. In the OASIS 1 trial, published in The Lancet, participants taking a 50 mg oral dose (higher than the currently approved 25 mg) lost an average of 15.1% of their body weight over 68 weeks, compared to 2.4% with a placebo. That’s roughly in line with the results seen in injectable Wegovy trials, which report average weight loss in the 12% to 17% range depending on the study and dose.
The 50 mg dose tested in OASIS 1 is not the same as the approved 25 mg tablet, so real-world results with the current pill may be somewhat lower. Still, the data confirms that oral semaglutide at high doses can produce meaningful weight loss, not just the modest effects seen with the lower-dose diabetes pill.
Side Effects Compared to the Injection
The side effect profile is similar between the two forms. Nausea, vomiting, and abdominal pain are the most common complaints with the pill, just as they are with the shot. Research comparing the two delivery methods has found “similar or better efficacy and similar tolerability” with the oral tablets versus most injectable GLP-1 medications.
One obvious difference: the pill eliminates injection site reactions, which some people experience with the weekly shot (redness, swelling, or irritation at the injection site). For people who are uncomfortable with needles or who travel frequently and don’t want to deal with refrigerated pens, the pill offers a practical alternative. The tradeoff is the daily dosing routine and the fasting requirement, which some people find inconvenient.
Oral Wegovy vs. Rybelsus
If you’ve heard of Rybelsus, you might wonder how it fits in. Rybelsus is also an oral semaglutide tablet, but it’s approved only for managing type 2 diabetes, not for weight loss. Its maximum dose is 14 mg daily, well below the 25 mg maintenance dose of oral Wegovy. Some doctors have prescribed Rybelsus off-label for weight loss, but at its approved dose, the weight loss effects are significantly smaller than what you’d get from Wegovy in either form.
Oral Wegovy is the first pill specifically approved for weight management, filling a gap that previously left people choosing between injectable Wegovy and off-label use of a diabetes medication at a lower dose.